Onsdag 30 April | 11:27:27 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2021-02-25 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-08-27 - Kvartalsrapport 2020-Q2
2020-05-08 - X-dag ordinarie utdelning QUICK 0.00 SEK
2020-05-07 - Årsstämma
2020-05-07 - Kvartalsrapport 2020-Q1
2020-02-27 - Bokslutskommuniké 2019
2019-11-05 - Kvartalsrapport 2019-Q3
2019-08-29 - Kvartalsrapport 2019-Q2
2019-05-08 - X-dag ordinarie utdelning QUICK 0.00 SEK
2019-05-07 - Årsstämma
2019-05-07 - Kvartalsrapport 2019-Q1
2019-03-07 - Split QUICK 10:1
2019-02-28 - Bokslutskommuniké 2018
2018-10-26 - Kvartalsrapport 2018-Q3
2018-08-24 - Kvartalsrapport 2018-Q2
2018-06-04 - Extra Bolagsstämma 2018
2018-05-04 - X-dag ordinarie utdelning QUICK 0.00 SEK
2018-05-03 - Årsstämma
2018-05-03 - Kvartalsrapport 2018-Q1
2018-02-16 - Bokslutskommuniké 2017
2017-11-22 - Extra Bolagsstämma 2017
2017-10-27 - Kvartalsrapport 2017-Q3
2017-08-25 - Kvartalsrapport 2017-Q2
2017-04-28 - X-dag ordinarie utdelning QUICK 0.00 SEK
2017-04-27 - Årsstämma
2017-04-27 - Kvartalsrapport 2017-Q1
2017-02-17 - Bokslutskommuniké 2016
2016-11-04 - Kvartalsrapport 2016-Q3
2016-11-02 - Extra Bolagsstämma 2016
2016-08-26 - Kvartalsrapport 2016-Q2
2016-05-13 - X-dag ordinarie utdelning QUICK 0.00 SEK
2016-05-12 - Årsstämma
2016-05-12 - Kvartalsrapport 2016-Q1
2016-02-26 - Bokslutskommuniké 2015

Beskrivning

LandSverige
SektorHälsovård
IndustriMedicinteknik
QuickCool är verksamma inom medicinteknik. Idag innehas inriktning mot utvecklandet av kylsystem som används vid kroppstemperaturreglering. Produkterna används huvudsakligen av intensivvårdspatienter med hjärtbesvär, där stoppet förorsakat skada på patientens hjärna. Tekniken fungerar via ballongkatetrar som förs in i näshålan och som kyler ned hjärnan. Bolaget etablerades under 2003 och har sitt huvudkontor i Lund.
2020-02-02 13:32:54

We welcome a new, eventful and exciting 2020!

During the first month of the decade, we have continued our development and documentation work. Negotiations regarding our long-term financing have continued, meetings with some subcontractors have been held, and we haveworked with the preparations for further patent applications as well as the application to the Swedish Medical Products Agency relating to our positioning strap (Class 1) that will be submitted in the next few weeks.

We started the year by visiting the factory where our Nasal Cooling Kits, the disposable items, will be produced. We save both time and ensure quality when using the machines we bought at the end of last year. The production of the first balloon catheters has worked well. We are very pleased with our cooperation with them.
The discussions regarding our long-term funding have continued with different parties and alternatives. We will publish updated information within a few weeks.

We have met with two subcontractors to discuss prices, forecasts and technical solutions.

We are preparing the documentation required for two different patent applications. We intend to submit one patent application during the month of March and the other during the month of April.

Additionally, we have been working on completing the technical file for the positioning strap (Class 1 product, which is part of the Nasal Cooling Kit) so that we can submit the application to the Swedish Medical Products Agency (Läkemedelsverket) next month.
The global sales of cooling systems amounted to more than USD 1,013 Million in 2018 and is estimated to grow at a CAGR of 6.34% between 2020-2027.

Good, positive growth in all markets in the next few years! Källa: www.ResearchNester.com

We are looking forward to a successful new decade, starting with 2020!

Follow us on LinkedIn. Additional information about QuickCool and our solution may be found on our homepage: http://www.quickcool.se/en/home.html

Kind regards,
Fredrik

Fredrik Radencrantz
CEO
QuickCool AB
Ideon Science Park
Beta 6, Scheelevägen 17 - SE-223 70 Lund - Sweden
E-mail: fredrik.radencrantz@quickcool.seWeb: www.quickcool.se
Mobile +46 (0)73 834 1188
QuickCool is a Swedish medical technology company, whose business concept is to save lives and prevent brain damage in acute ischemia (Inadequate blood supply to the brain) by developing and providing a unique and globally patented cooling system, the QuickCool[®] SYSTEM. QuickCool is active in the fast-growing market, Targeted Temperature Management (TTM), for brain-protective cooling treatment of patients with e.g. acute cardiac arrest and stroke. QuickCool's solution protects the brain by cooling in the nasal cavity and thus takes advantage of the innate heat exchanger in the nose. QuickCool's Intranasal method offers gentle and uninterrupted cooling treatment for sedated patients. QuickCool is listed on Spotlight Stock Market and conducts its business at Ideon Science Park in Lund. For more Information, please refer to www.quickcool